Skip to main content
. 2020 Dec 24;27(1):1073274820983025. doi: 10.1177/1073274820983025

Table 2.

ROC Analysis AUC, Sensitivity and Specificity Results.

Cut-off (ng/ml) AUC, % (95%CI) Sensitivity, % (95% CI) Specificity, % (95% CI) P
NPC Abbott 0.60 63.1 (52.9-72.5) 48.98 (34.4-63.7) 80.77 (67.5-90.4) 0.0051
Roche 1.09 56.1 (45.9-66.0) 51.02 (36.3-65.6) 71.15 (56.9-82.9)
HNSC Abbott 1.60 48.7 (38.1-59.4) 23.08 (11.1-39.3) 94.23 (84.1-98.8) 0.9275
Roche 1.20 49.8 (39.2-60.5) 53.85 (37.2-69.9) 61.54 (47.0-74.7)
ESCC Abbott 1.60 62.2 (53.2-70.6) 46.67 (35.1-58.6) 94.23 (84.1-98.8) 0.4688
Roche 1.87 60.7 (51.7-69.3) 48.00 (36.3-59.8) 90.38 (79.0-96.8)
LSCC Abbott 1.20 78.7 (69.6-86.1) 64.15 (49.8-76.9) 84.62 (71.9-93.1) 0.0066
Roche 1.87 73.2 (63.7-81.4) 58.49 (44.1-71.9) 90.38 (79.0-96.8)
BC Abbott 1.50 55.0 (44.9-64.8) 25.00 (14.0-38.9) 92.31 (81.5-97.9) 0.8093
Roche 1.74 54.3 (44.2-64.1) 34.62 (22.0-49.1) 86.54 (74.2-94.4)
CSCC Abbott 1.30 79.4 (69.9-87.0) 65.12 (49.1-79.0) 90.38 (79.0-96.8) 0.2264
Roche 1.87 77.0 (67.3-85.0) 62.79 (46.7-77.0) 90.38 (79.0-96.8)